重大事件
外國發行人報告
6-K
2026-06-08
Galmed Pharmaceuticals提交6-K 附27份文件涉重大協議及業務更新
AI 繁中摘要
Galmed Pharmaceuticals Ltd.（納斯達克代碼：GLMD）於2026年6月8日向美國證監會提交了一份6-K表格，報告外國發行人最新重大事項。是次申報共附27份文件，包括一項重大協議（EX-10.1）、獨立註冊會計師事務所同意書（EX-23.1）以及多份新聞稿與展示材料（EX-99.1至EX-99.4），並附有大量圖表。📄
雖然6-K主體未有詳細披露具體財務數字或業績指引，但從文件組合推測，公司可能發布了臨床試驗進展、業務合作或公司戰略更新等關鍵信息。投資者應重點查閱附件內容，特別是EX-99.1至EX-99.4的新聞稿及說明材料，以掌握影響股價的即時消息。⚕️
目前未有管理層展望直接引述，亦未提供季度或年度財務摘要。建議關注該公司後續發布的正式公告及10-Q/10-K申報，以獲取更全面的財務狀況與經營成果分析。📊
*備註：由於申報文件原文未摘錄具體數字，本摘要僅基於文件列表及行業慣例撰寫，實際投資決策請參閱SEC網站完整文本。*
展開英文正文
EDGAR Filing Documents for 0001493152-26-027640 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001493152-26-027640 Filing Date 2026-06-08 Accepted 2026-06-08 08:26:15 Documents 27 Period of Report 2026-06-08 Document Format Files Seq Description Document Type Size 1 6-K form6-k.htm 6-K 149271 2 EX-10.1 ex10-1.htm EX-10.1 749591 3 EX-23.1 ex23-1.htm EX-23.1 6241 4 EX-99.1 ex99-1.htm EX-99.1 356196 5 EX-99.2 ex99-2.htm EX-99.2 178773 6 EX-99.3 ex99-3.htm EX-99.3 10051 7 EX-99.4 ex99-4.htm EX-99.4 22840 8 GRAPHIC ex99-1_001.jpg GRAPHIC 16701 9 GRAPHIC form6-k_001.jpg GRAPHIC 66453 10 GRAPHIC form6-k_002.jpg GRAPHIC 21031 11 GRAPHIC form6-k_003.jpg GRAPHIC 69527 12 GRAPHIC form6-k_004.jpg GRAPHIC 81336 13 GRAPHIC ex99-4_001.jpg GRAPHIC 28418 14 GRAPHIC ex99-3_001.jpg GRAPHIC 416021 15 GRAPHIC ex99-3_002.jpg GRAPHIC 1109937 16 GRAPHIC ex99-3_003.jpg GRAPHIC 287224 17 GRAPHIC ex99-3_004.jpg GRAPHIC 420682 18 GRAPHIC ex99-3_005.jpg GRAPHIC 410679 19 GRAPHIC ex99-3_006.jpg GRAPHIC 451037 20 GRAPHIC ex99-3_007.jpg GRAPHIC 406461 21 GRAPHIC ex99-3_008.jpg GRAPHIC 316735 22 GRAPHIC ex99-3_009.jpg GRAPHIC 440648 23 GRAPHIC ex99-3_010.jpg GRAPHIC 512394 24 GRAPHIC ex99-3_011.jpg GRAPHIC 777376 25 GRAPHIC ex99-3_012.jpg GRAPHIC 584433 26 GRAPHIC ex99-3_013.jpg GRAPHIC 380293 27 GRAPHIC ex99-3_014.jpg GRAPHIC 434990 Complete submission text file 0001493152-26-027640.txt 11438165 Mailing Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608 Business Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608 97236938448 Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings) EIN.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231 Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 261071103 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)